Scott Henry
Stock Analyst at Alliance Global Partners
(1.70)
# 3,073
Out of 4,786 analysts
60
Total ratings
40.38%
Success rate
-4.38%
Average return
Main Sectors:
Stocks Rated by Scott Henry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QSI Quantum-Si incorporated | Initiates: Buy | $3.75 | $1.20 | +212.50% | 1 | Feb 7, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $8.25 → $6 | $2.85 | +110.53% | 4 | Nov 19, 2024 | |
| LPCN Lipocine | Initiates: Buy | $10 | $3.18 | +214.47% | 1 | Sep 24, 2024 | |
| ASRT Assertio Holdings | Initiates: Buy | $2.75 | $0.67 | +307.65% | 1 | May 28, 2024 | |
| DERM Journey Medical | Initiates: Buy | $8.5 | $5.90 | +44.07% | 2 | Feb 16, 2024 | |
| RNXT RenovoRx | Initiates: Buy | $4 | $0.99 | +304.04% | 3 | Feb 2, 2024 | |
| FBIO Fortress Biotech | Maintains: Buy | $30 → $15 | $1.56 | +861.54% | 2 | Nov 29, 2023 | |
| RVPH Reviva Pharmaceuticals Holdings | Reiterates: Buy | $12 | $0.95 | +1,158.13% | 2 | Oct 30, 2023 | |
| CSBR Champions Oncology | Maintains: Buy | $9 → $7.5 | $8.68 | -13.59% | 2 | Sep 22, 2023 | |
| DCTH Delcath Systems | Maintains: Buy | $10 → $13 | $12.73 | +2.12% | 4 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $24 | $24.15 | -0.62% | 2 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $105.14 | -14.40% | 9 | Dec 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $16 | $24.25 | -36.08% | 2 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $58 | $83.90 | -30.87% | 6 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $36 | $52.48 | -31.40% | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $0.99 | +1,011.11% | 3 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $4.73 | +26.85% | 2 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6,000 → $5,750 | $2.07 | +277,677.78% | 1 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.79 | - | 1 | Dec 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $7 | $4.80 | +45.83% | 3 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $17.88 | - | 5 | Apr 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.59 | - | 2 | Mar 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.53 | - | 1 | Nov 10, 2017 |
Quantum-Si incorporated
Feb 7, 2025
Initiates: Buy
Price Target: $3.75
Current: $1.20
Upside: +212.50%
Vivos Therapeutics
Nov 19, 2024
Maintains: Buy
Price Target: $8.25 → $6
Current: $2.85
Upside: +110.53%
Lipocine
Sep 24, 2024
Initiates: Buy
Price Target: $10
Current: $3.18
Upside: +214.47%
Assertio Holdings
May 28, 2024
Initiates: Buy
Price Target: $2.75
Current: $0.67
Upside: +307.65%
Journey Medical
Feb 16, 2024
Initiates: Buy
Price Target: $8.5
Current: $5.90
Upside: +44.07%
RenovoRx
Feb 2, 2024
Initiates: Buy
Price Target: $4
Current: $0.99
Upside: +304.04%
Fortress Biotech
Nov 29, 2023
Maintains: Buy
Price Target: $30 → $15
Current: $1.56
Upside: +861.54%
Reviva Pharmaceuticals Holdings
Oct 30, 2023
Reiterates: Buy
Price Target: $12
Current: $0.95
Upside: +1,158.13%
Champions Oncology
Sep 22, 2023
Maintains: Buy
Price Target: $9 → $7.5
Current: $8.68
Upside: -13.59%
Delcath Systems
Aug 16, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $12.73
Upside: +2.12%
May 3, 2023
Maintains: Buy
Price Target: $19 → $24
Current: $24.15
Upside: -0.62%
Dec 23, 2022
Maintains: Buy
Price Target: $85 → $90
Current: $105.14
Upside: -14.40%
Aug 24, 2022
Downgrades: Neutral
Price Target: $10 → $16
Current: $24.25
Upside: -36.08%
Aug 3, 2021
Maintains: Neutral
Price Target: $55 → $58
Current: $83.90
Upside: -30.87%
Aug 2, 2021
Maintains: Buy
Price Target: $32 → $36
Current: $52.48
Upside: -31.40%
May 12, 2021
Maintains: Buy
Price Target: $9 → $11
Current: $0.99
Upside: +1,011.11%
Feb 26, 2021
Maintains: Buy
Price Target: $4 → $6
Current: $4.73
Upside: +26.85%
Feb 16, 2021
Maintains: Buy
Price Target: $6,000 → $5,750
Current: $2.07
Upside: +277,677.78%
Dec 4, 2020
Downgrades: Neutral
Price Target: n/a
Current: $2.79
Upside: -
Nov 11, 2020
Upgrades: Buy
Price Target: $7
Current: $4.80
Upside: +45.83%
Apr 18, 2019
Upgrades: Buy
Price Target: n/a
Current: $17.88
Upside: -
Mar 26, 2018
Downgrades: Neutral
Price Target: n/a
Current: $0.59
Upside: -
Nov 10, 2017
Downgrades: Neutral
Price Target: n/a
Current: $3.53
Upside: -